Catalyst Rx Health Initiatives, Inc. Sustainability Profile
Catalyst Rx Health Initiatives, Inc., commonly referred to as Catalyst Rx, is a prominent player in the healthcare industry, headquartered in the United States. Founded in 2003, the company has established itself as a leader in pharmacy benefit management and healthcare solutions, serving clients across various regions in the US. Catalyst Rx offers a range of innovative services, including prescription drug management, clinical programmes, and cost-containment strategies, all designed to enhance patient care while optimising healthcare expenditures. What sets Catalyst Rx apart is its commitment to personalised service and data-driven insights, ensuring tailored solutions for its diverse clientele. With a strong market position, Catalyst Rx has achieved notable milestones, including strategic partnerships and recognition for its effective healthcare initiatives. The company continues to drive advancements in the pharmacy benefit landscape, making a significant impact on the health and well-being of its members.
DitchCarbon Score
How does Catalyst Rx Health Initiatives, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Retail Trade Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Catalyst Rx Health Initiatives, Inc.'s score of 72 is higher than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Catalyst Rx Health Initiatives, Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. However, the company is part of a corporate family that includes UnitedHealth Group Incorporated, from which it inherits climate commitments and performance data. As a merged entity, Catalyst Rx aligns its climate initiatives with those of UnitedHealth Group, which has established significant sustainability goals. While specific reduction targets for Catalyst Rx are not detailed, the overarching commitments from UnitedHealth Group may influence its climate strategy. This includes participation in initiatives such as the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), both of which are cascaded down to Catalyst Rx at a level 7 relationship. Although no specific reduction targets or achievements are listed for Catalyst Rx, the company's affiliation with UnitedHealth Group suggests a commitment to addressing climate change and reducing carbon emissions in line with industry standards. As the landscape of corporate sustainability evolves, Catalyst Rx is positioned to adopt and implement effective climate strategies in the future.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 15,838,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 161,303,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 146,373,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 |
How Carbon Intensive is Catalyst Rx Health Initiatives, Inc.'s Industry?
How Carbon Intensive is Catalyst Rx Health Initiatives, Inc.'s Location?
Catalyst Rx Health Initiatives, Inc.'s Scope 3 Categories Breakdown
Catalyst Rx Health Initiatives, Inc.'s Scope 3 emissions, which decreased by 3% last year and increased significantly since 2016, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Investments" being the largest emissions source at 51% of Scope 3 emissions.
Top Scope 3 Categories
Catalyst Rx Health Initiatives, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Catalyst Rx Health Initiatives, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
